Brief: Ironwood Pharmaceuticals Reports First Quarter 2022 Results
May 5 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O :
* IRONWOOD PHARMACEUTICALS REPORTS FIRST QUARTER 2022
RESULTS;
MAINTAINS FULL YEAR 2022 FINANCIAL GUIDANCE
* IRONWOOD PHARMACEUTICALS INC QTRLY TOTAL REVENUE OF $98
MILLION
* IRONWOOD PHARMACEUTICALS INC QTRLY GAAP NET INCOME PER
SHARE
-DILUTED $0.21
* IRONWOOD PHARMACEUTICALS INC QTRLY NON-GAAP NET INCOME PER
SHARE
- DILUTED $0.21
Source text for Eikon: ID:nBw4BHqTxa
Further company coverage: IRWD.O
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation